VBI Vaccines, Inc. (NASDAQ:VBIV): Joseph Edelman’s Perceptive Advisors filed an amended 13D.
You can check out Perceptive Advisors’ latest holdings and filings here.
Please follow Perceptive Advisors (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Perceptive Advisors or update its stock holdings.
Follow Joseph Edelman's Perceptive Advisors
You can access the original SEC filing by clicking here.
Ownership Summary Table
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Perceptive Advisors | 0 | 11,414,549 | 0 | 11,414,549 | 11,414,549 | 17.9% |
| Joseph Edelman | 0 | 11,414,549 | 0 | 11,414,549 | 11,414,549 | 17.9% |
| Perceptive Life Sciences Master Fund, Ltd | 0 | 9,345,725 | 0 | 9,345,725 | 9,345,725 | 15.1% |
| Perceptive Credit Holdings | 0 | 2,068,824 | 0 | 2,068,824 | 2,068,824 | 3.2% |
Follow Joseph Edelman's Perceptive Advisors
Page 1 of 7 – SEC Filing
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13D
THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 2)*
VBI Vaccines
Inc.
(Name of Issuer)
Common
Shares, no par value per share
(Title of Class of Securities)
91822J 10 3
(CUSIP
Number)
Alexander Rakitin
Perceptive Advisors LLC
51 Astor Place, 10th Floor
New York, NY 10003
(646)
205-5340
(Name, Address and Telephone Number of Person Authorized to Receive Notices and
Communications)
October 26, 2017
(Date of Event Which Requires Filing of this Statement)
If the filing person has
previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13D-1(e),
240.13d-1(f) or 240.13d-1(g), check the following box ☐.
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.
The remainder of this cover page shall be filled out
for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities
Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
